Welcome to our dedicated page for Proto Labs news (Ticker: PRLB), a resource for investors and traders seeking the latest updates and insights on Proto Labs stock.
Proto Labs, Inc. reports company developments tied to its digital manufacturing services for custom parts, from prototyping through end-use production. Protolabs serves product developers, engineers, procurement teams, and supply chain groups through capabilities that include CNC machining, injection molding, 3D printing, and sheet metal fabrication, using its own manufacturing facilities and a network of manufacturing partners.
Recurring PRLB news includes quarterly financial results, service-line performance such as CNC machining, margin and cash-flow commentary, product and platform updates such as ProDesk, aerospace manufacturing capabilities, industry research on digital adoption and artificial intelligence, investor conference participation, and leadership-team changes. Company updates also describe strategic priorities around customer experience, innovation, production capacity, and operating efficiency.
Protolabs (NYSE: PRLB) announced its participation in two upcoming major conferences. On June 4, 2024, at 9 a.m. EDT, CEO Rob Bodor will present at the Manufacturing Leadership Council’s ‘Rethink: Accelerating Digital Transformation in Manufacturing’ Summit, discussing the company's Manufacturing 4.0 journey. On June 6, 2024, at 9 a.m. EDT, Bodor will present at William Blair's 44th Annual Growth Stock Conference, covering Protolabs’ operational and financial trends. Both presentations will be available via live webcast, with replays accessible on the company’s investor relations website for 90 days.
Protolabs, Inc. reported strong financial results for Q1 2024 with a total revenue of $128 million, up 1.6% YoY. The revenue from Protolabs Network saw a significant increase of 39% YoY to $24 million. GAAP earnings per share were $0.20, while non-GAAP earnings per share stood at $0.40. The company remains focused on driving profitable growth and enhancing shareholder value.
Protolabs (NYSE: PRLB) collaborates with BioDapt to create custom prosthetics for elite athletes, including Paralympians, through its innovative digital manufacturing services. Founder Mike Schultz, a Paralympic Gold Medalist, leads BioDapt in designing high-performance prosthetic equipment. Protolabs' quick-turn manufacturing capabilities have been important in supporting BioDapt's mission to provide elite adaptive athletes with custom parts that enhance their athletic performance. The partnership has allowed athletes like Noelle Lambert to pursue their Paralympic dreams with cutting-edge prosthetic solutions.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.